|49.71||+0.01 / +0.02%|
Data as of 4:00pm ET
|49.74||+0.0274 / +0.06%|
The 9 analysts offering 12-month price forecasts for ViroPharma Inc have a median target of 43.00, with a high estimate of 50.00 and a low estimate of 27.00. The median estimate represents a -13.50% decrease from the last price of 49.71.
The current consensus among 12 polled investment analysts is to Hold stock in ViroPharma Inc. This rating has held steady since November, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.